halofenate has been researched along with Coronary Disease in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Colman, RW | 1 |
Aronow, WS; King, J; Moorthy, K; Papageorge's, NP; Vawter, M; Vicario, MD | 1 |
Aronow, WS; Harding, PR; Khemka, M; Khursheed, M; Nelson, WH; Pagano, J; Papageorge's, NP; Vangrow, JS | 2 |
Aronow, WS; Khemka, M; Pagano, J; Papageorge's, NP; Vangrow, J; Vawter, M | 1 |
4 trial(s) available for halofenate and Coronary Disease
Article | Year |
---|---|
Long-term efficacy of halofenate on serum triglyceride levels.
Topics: Cholesterol; Clinical Trials as Topic; Coronary Disease; Depression, Chemical; Female; Glycolates; Halofenate; Humans; Male; Middle Aged; Placebos; Time Factors; Triglycerides; Uric Acid | 1975 |
Halofenate: an effective hypolipemia- and hypouricemia-inducing drug.
Topics: Adult; Clinical Trials as Topic; Coronary Disease; Depression, Chemical; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Middle Aged; Time Factors; Triglycerides; Uric Acid | 1973 |
Long-term effect of halofenate on serum lipids.
Topics: Adult; Aged; Cholesterol; Clinical Trials as Topic; Coronary Disease; Female; Halofenate; Humans; Hypolipidemic Agents; Lipids; Male; Middle Aged; Placebos; Triglycerides; Uric Acid | 1974 |
Halofenate, serum lipids, and exercise performance in coronary heart disease.
Topics: Adult; Aged; Angina Pectoris; Cholesterol; Clinical Trials as Topic; Coronary Disease; Female; Glycolates; Halofenate; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Male; Middle Aged; Physical Exertion; Time Factors; Triglycerides | 1974 |
1 other study(ies) available for halofenate and Coronary Disease
Article | Year |
---|---|
The role of platelets in the genesis of ischemia.
Topics: Adenosine Diphosphate; Animals; Arteriosclerosis; Blood Platelets; Cholesterol; Clofibrate; Coronary Disease; Cyclic AMP; Death, Sudden; Diabetes Complications; Diabetes Mellitus; Halofenate; Humans; Hyperlipoproteinemia Type II; Platelet Aggregation; Prostaglandins; Smoking; Swine; Thrombin | 1982 |